- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03349047
Anxiety About Casual Exposure to Food Allergens (TOUCH)
February 20, 2019 updated by: Icahn School of Medicine at Mount Sinai
Trial To Reduce Food Allergy Anxiety by Holding the Allergen (TOUCH Study)
Living with food allergy may result in anxiety and reduced quality of life.
Food allergic patients and their families are often concerned about casual exposure with the offending allergen through skin contact or being near the offending food, which is actually very low risk.
This concern can limit social activities and increase stress.
The aim of this study is to provide a behavioral intervention consisting of having peanut/tree nut allergic patients hold a cup with a peanut or tree nut to which the patient is allergic to and touching it.
The goal is to reduce anxiety about casual exposure to food allergens and improve quality of life for patients with food allergies and their families.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of the present study is to determine if having patients (ages 9-17) who are peanut and/or tree nut allergic, and endorse anxiety/discomfort about non-ingestion exposure, hold and touch their offending allergen in addition to education leads to reduced discomfort for both patient and caregiver compared to education alone.
The primary outcome measure is immediate differences in the score obtained on a child-reported scale in response to a question assessing how worried the patient is about the thought of being near or touching peanut or tree nut from pre-intervention to immediate post-intervention when compared between an intervention (education and touching) and a control group (education only).
Secondary outcome measures include: difference between and within groups of child-reported scales regarding questions assessing patients worry regarding casual exposure immediately and one month post intervention within and between groups, differences between and within groups on a parent-reported scale regarding parental worry about casual exposure to food allergen immediately and one month post intervention within and between groups, differences between and within groups on a parent-proxy measures regarding child worry about casual exposure to food allergen immediately and one month post intervention within and between groups, improvement in child anxiety and parent-proxy measures of anxiety from pre-intervention to one month post-intervention within and between groups and improvement in parent-proxy measures of quality of life from pre-intervention to one month post-intervention within and between groups.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10029
- Icahn School of Medicine at Mount Sinai
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
9 years to 17 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age: 9 years to 17.5 years
- Patient seen in the outpatient clinic (no inpatients).
- Patient and or caretaker endorses anxiety about being in proximity with or touching peanut
- Patients must have been diagnosed with a peanut and or tree nut allergy
Exclusion Criteria:
- Patients and caregiver(s) without ability to understand the study, as determined by either: a previously diagnosed cognitive disability or inability to repeat the study protocol at the time of consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Behavioral Intervention
Behavioral Intervention Group - Education regarding nut allergy and will also have contact with nut.
|
Patients will hold the peanut or tree nut in a cup and will be asked to touch the nut with their finger.
The group will be educated about what can occur with contact with or being in proximity of peanuts or tree nuts.
|
Placebo Comparator: Control
Education regarding nut allergy
|
The group will be educated about what can occur with contact with or being in proximity of peanuts or tree nuts.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Child worry about casual exposure
Time Frame: Baseline and approximately 10 minutes
|
Change in a child-reported 10-point likert scale assessing how worried the child is about the thought of being near or touching peanut or tree nut, where 0 is not worried at all and 10 is extremely worried pre-intervention compared to immediately post-intervention.
|
Baseline and approximately 10 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Parent worry about casual exposure
Time Frame: Baseline and one month
|
Parent-proxy reported scale in response to additional questions assessing how worried the child is about the thought of being near or touching peanut or tree nut, where 0 is not worried at all and 10 is extremely worried, at one month compared to baseline.
|
Baseline and one month
|
Food Allergy Quality of Life-Parental Burden (FAQL-PB) Questionnaire
Time Frame: One month
|
The score obtained on a parent-reported quality of life questionnaire (QOL).
QOL is measured on a standardized FAQL-PB questionnaire which consists of 17 questions and responses are measured on a 6-point likert scale where 0 is not limited and 6 is very limited with total from 0 to 102.
|
One month
|
The Screen for Child Anxiety Related Disorders (SCARED)
Time Frame: Baseline and one month
|
Change in child anxiety at one month compared to baseline.The SCARED consists of 17 items, rated on a 3 point Likert-type scale.
Total score range from 0 (not anxious) to 34 (very anxious).
|
Baseline and one month
|
SCARED - parent version
Time Frame: Baseline and one month
|
Change in parent-proxy measures of child anxiety on parent reported SCARED at one month compared to baseline.
17 items, rated on a 3 point Likert-type scale.
Total score range from 0 (not anxious) to 34 (very anxious).
|
Baseline and one month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 15, 2017
Primary Completion (Actual)
June 13, 2018
Study Completion (Actual)
June 13, 2018
Study Registration Dates
First Submitted
November 17, 2017
First Submitted That Met QC Criteria
November 17, 2017
First Posted (Actual)
November 21, 2017
Study Record Updates
Last Update Posted (Actual)
February 21, 2019
Last Update Submitted That Met QC Criteria
February 20, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GCO 17-1957
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Food Allergy
-
Vilnius UniversityEnrolling by invitationFood Allergy in Children | Food Allergy in InfantsLithuania
-
Vilnius UniversityEnrolling by invitationFood Allergy in Children | Food Allergy in InfantsLithuania
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Chinese University of Hong KongRecruiting
-
King's College LondonKing's College Hospital NHS Trust; University College London Hospitals; Cambridge... and other collaboratorsRecruitingEgg Allergy | Food Allergy | Food Allergy in Children | Milk Allergy | Food Allergy in Infants | Nut Allergy | Food Allergen SensitisationUnited Kingdom
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustUnknownEgg Allergy | Food Allergy | Food Allergy in Children | Milk Allergy | Food Allergy in Infants | Nut Allergy | Food Allergen SensitisationUnited Kingdom
-
Stanford UniversityRecruitingFood Allergy | Food Allergy in ChildrenUnited States
-
Rhode Island HospitalCompletedFood Allergy in Children
-
University Hospital, MontpellierUnknownFood Allergy Suspected | Food Allergy ProvedFrance
-
Rhode Island HospitalVirtually Better, Inc.CompletedFood Allergy in Children
Clinical Trials on Behavioral intervention group
-
University of WashingtonNot yet recruitingHypertension | Health Behavior | Dietary Modification
-
VA Office of Research and DevelopmentDallas VA Medical CenterCompletedDepression | Aging | Chronic Back PainUnited States
-
University of Texas Southwestern Medical CenterActive, not recruiting
-
Emory UniversityCenters for Disease Control and PreventionCompleted
-
Tehran University of Medical SciencesCompletedAnxiety DisordersIran, Islamic Republic of
-
VA Office of Research and DevelopmentMichael E. DeBakey VA Medical Center; Dallas VA Medical CenterRecruitingDepression | Musculoskeletal Pain | Aging | Chronic Back PainUnited States
-
Universidad de GranadaCompletedStress, Psychological | Vision Disorders | Self Efficacy | PsychopathySpain
-
Emory UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)TerminatedDiabetes Mellitus, Type 2United States
-
Queen's UniversityCanadian Institutes of Health Research (CIHR)Completed
-
National Taiwan University HospitalShin Kong Wu Ho-Su Memorial HospitalCompletedTreatment-resistant DepressionTaiwan